Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Hughes Institute studying BTK-specific inhibitor LFM-A13

Dec. 8, 1998

Xcellerate-based therapy shows promising results in otherwise untreatable cancer patients

Dec. 8, 1998

PSC-833 plus chemotherapy is safe and effective in older patients with AML

Dec. 7, 1998

Isis patents antisense oligonucleotides for cancer treatment

Dec. 7, 1998

FDA approves Hycamtin as second-line treatment of small cell lung cancer

Dec. 4, 1998

Maxia initiates pivotal phase III trial with MX-6 for treatment of CIN

Dec. 4, 1998

Accutin, an RGD-containing peptide with angiogenesis-inhibitory activity

Dec. 3, 1998

Adozelesin displays marginal efficacy in previously untreated metastatic breast cancer

Dec. 3, 1998

IntraBiotics receives milestone payment from Pharmacia & Upjohn

Dec. 3, 1998

Lack of cardiotoxicity of SM-5887 confirmed in dogs

Dec. 2, 1998

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...